Dr. Pagdin Bioidentical Hormone Replacement Therapy for Men
Related Posts
Dr. Pagdin Bioidentical Hormone Replacement Therapy for Men
A surge of interest and research in potential alternatives to conventional hormone therapy has taken place. Despite a lack of evidence to support its safety and efficacy, one of those alternatives, Bioidentical Hormone Replacement Therapy (BHRT), has been used for the treatment of male hormonal conditions (e.g., andropause, thyropause, and adrenopause) through the use of bioidentical plant- and extract-based compounds. This Circle aims to remotely collect patient-reported symptoms and health-related, quality-of-life data among male patients pre- and post-administration of BHRT. To collect these data, this Circle will utilize the Aging Male Symptoms Scale (AMS). Enrolled patients will be followed for 18 months following the administration of BHRT and will complete patient-reported outcome measures on a quarterly basis following treatment. The collection of real-world data from this Circle will provide additional evidence in determining the safety and efficacy of BHRT among male patients.
Aging Male Symptoms Scale (AMS)
Bioidentical Hormone Replacement Therapy (BHRT)
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.